论文部分内容阅读
目的:探讨利巴韦林联合热毒宁对治疗小儿登革热的临床疗效及安全性。方法:选取我院儿科的30例小儿登革热的患者,随机分为两组,实验组和对照组,分别为15人,实验组15例给患者注射利巴韦林+热毒宁进行治疗,对照组15例只给患者注射利巴韦林进行治疗,观察两组患者的退热时间以及是否有出现不良反应。结果:给予小儿登革热患者采用联合热毒宁的治疗方案,可有效的缓解患儿的症状,缩短治疗时间,减少患儿的不良反应,能显著提高临床疗效。结论:利巴韦林联合热毒宁能有效的提高登革热的临床疗效,如果应用于临床疗效的话,会更患者带来更多的益处。
Objective: To investigate the clinical efficacy and safety of ribavirin combined with Renduining in treating children’s dengue fever. Methods: Thirty cases of pediatric dengue fever in pediatrics of our hospital were randomly divided into two groups: experimental group and control group, with 15 patients respectively. In the experimental group, 15 patients were treated with ribavirin + Only 15 patients were treated with ribavirin injection, and the antipyretic time and adverse reactions in both groups were observed. Results: The treatment of Dengue Ning given to children with dengue fever treatment can effectively alleviate the symptoms of children, shorten the treatment time, reduce the adverse reactions in children, can significantly improve the clinical efficacy. Conclusion: Ribavirin combined with Revedynin can effectively improve the clinical efficacy of dengue fever, if used in clinical efficacy, it will bring more benefits to patients.